Scenarios that move PODD
Insulet Corporation - Common Stock
Scenarios that move PODD: 6 analyses, 1 positive, 5 negative.
- · Lilly reports strong weight loss results for new drug — ▼ · impact -24 · confidence low · horizon quarters
- · Novo and Hengrui sign exclusive license for oral GLP-1/GIP drug — ▼ · impact -50 · confidence low · horizon quarters
- · Beta Bionics stock plunges 37% after safety issues emerge — ▲ · impact +62 · confidence high · horizon weeks
- · ◇ What if… Oral GLP-1 drugs replace injectable treatments — ▼ · impact -40 · confidence low · horizon quarters
- · Viking Therapeutics stock skyrockets in Tuesday trading — ▼ · impact -11 · confidence low · horizon quarters
- · Beta Bionics prices public offering of stock and warrants — ▼ · impact -30 · confidence medium · horizon quarters